Top Stock Picks Portfolio Comments
2018-12-12: Watch List candidates **** and **** triggered their buy points and were purchased for the GSA Portfolio at HALF size each. Both are in the **** ranked **** Industry Group.
Current Stock Portfolio Positions: CT** (+1%), HL** (+1%), US** (-2%),
| || |
Past Top Stock Pick Learn from these chart patterns. (Past performance does not guarantee future results)
Up 33% from $8.55 (2017-05-22)
On May 22, 2017 we profiled Oramed Pharmaceuticals Inc (ORMP) as a Top Stock Pick
to our members at $8.55. Within a period of six months, ORMP rose to a high of $11.34, for a return at it's peak of 33%. Obviously, one cannot sell exactly at the peak, but here is what we had observed about ORMP:
- GSA Rank: 62.94 (Our proprietary ranking for ORMP using fundamental AND technical factors)
- Accum/Dist Rank: 1.61 (Up vs. down volume action of ORMP taken over several weeks)
- Industry Group Rank: 4 (ORMP was in an industry showing strong group action)
Most importantly, ORMP was trading just 9.5% off it's 52-week high price, and had a breakout from a sideways price consolidation pattern, a clear signal to time our position. It is imperative to not only buy the best stocks that are fundamentally sound, but also to time your purchase correctly.